Technologies

Creative Biolabs Advances Integrated Target and TME Workflows to Accelerate Pancreatic Cancer Immunotherapy Research

  • by

Creative Biolabs, a senior provider in biotechnology and life sciences, today announced an enhancement to its specialized oncology research portfolio. Shirley, New York, United States, May 26, 2026 — By integrating high-affinity antibodies targeting Epithelial-Mesenchymal… Read More »Creative Biolabs Advances Integrated Target and TME Workflows to Accelerate Pancreatic Cancer Immunotherapy Research

JOYY Reports First Quarter 2026 Financial Results: Total Revenue Up 12.4% YoY, Substantially Expanding Shareholder Returns

  • by

​ SINGAPORE, May 26, 2026 /PRNewswire/ — JOYY Inc. (NASDAQ: JOYY) (“JOYY” or the “Company”), a leading global technology company, today announced its unaudited financial results for the first quarter ended March 31, 2026. In… Read More »JOYY Reports First Quarter 2026 Financial Results: Total Revenue Up 12.4% YoY, Substantially Expanding Shareholder Returns